ArticleClinical and experimental immunology2026
Nebivolol prevents exhausted T cells and enhances cytotoxicity against MCF-7 breast cancer cells in a β2-adrenergic receptor-dependent manner.
Mehri Hajiaghayi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.